title: Emergence of erosive polyarthritis coincident with Mycobacterium kansassi pulmonary infection in a patient with systemic sclerosis-rheumatoid arthritis overlap syndrome.
authors.forename: H
authors.initials: H
authors.lastname: Iwata
authors.forename: M
authors.initials: M
authors.lastname: Kinoshita
authors.forename: M
authors.initials: M
authors.lastname: Sumiya
authors.forename: A
authors.initials: A
authors.lastname: Iwai
authors.forename: S
authors.initials: S
authors.lastname: Aotsuka
authors.forename: D
authors.initials: D
authors.lastname: Hirata
authors.forename: S
authors.initials: S
authors.lastname: Minota
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D001426:Bacterial Proteins; D018834:Chaperonin 60; D018833:Chaperonins / Q000276:immunology; D005260:Female; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D019909:Mycobacterium kansasii / Q000302:isolation & purification*; D012217:Rheumatoid Factor / Q000097:blood; D012595:Scleroderma, Systemic / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D013577:Syndrome; D014397:Tuberculosis, Pulmonary / Q000097:blood / Q000150:complications* / Q000188:drug therapy
chemical_list: D000995:Antitubercular Agents; D001426:Bacterial Proteins; D018834:Chaperonin 60; D007075:Immunoglobulin M; C074119:heat-shock protein 65, Mycobacterium; D012217:Rheumatoid Factor; D018833:Chaperonins